A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities

BACKGROUND: The efficacy of epidermal growth factor (EGF) receptor (EGFR) inhibitors in patients with non‐small cell lung cancer (NSCLC), pancreatic cancer (PC), or colorectal cancer (CRC) has been demonstrated. However, dermatological reactions to these inhibitors can cause significant physical and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Kim, Young Saing, Ji, Jun Ho, Oh, Sung Yong, Lee, Suee, Huh, Seok Jae, Lee, Ji Hyun, Song, Ki‐Hoon, Son, Choon Hee, Roh, Mee Sook, Lee, Gyeong Won, Lee, Jeeyun, Kim, Seung Tae, Kim, Chan Kyu, Jang, Joung Soon, Hwang, In Gyu, Ahn, Hee Kyung, Park, Lee Chun, Oh, So Yeon, Kim, Seong‐Geun, Lee, Sang‐Cheol, Lim, Do‐Hyoung, Lee, Soon Il, Kang, Jung Hun
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2019
Sujets:
Symptom Management and Supportive Care
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964120/
https://ncbi.nlm.nih.gov/pubmed/31492766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0221
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires